Axovant Sciences Ltd. | Income Statement
Fiscal year is April-March. All values USD Thousands.
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
-
14.00
249.00
3,083.00
Gross Income
-
14.00
249.00
3,083.00
SG&A Expense
21,046.10
133,148.00
180,250.00
204,200.00
EBIT
21,046.10
133,162.00
180,499.00
207,283.00
Unusual Expense
-
-
-
6,035.00
Non Operating Income/Expense
-
-
369.00
211.00
Interest Expense
-
-
1,143.00
7,545.00
Pretax Income
21,046.10
133,162.00
182,011.00
220,652.00
Income Tax
1.00
17.00
1,060.00
921.00
Consolidated Net Income
21,047.00
133,145.00
180,951.00
221,573.00
Net Income
21,047.00
133,145.00
180,951.00
221,573.00
Net Income After Extraordinaries
21,047.00
133,145.00
180,951.00
221,573.00
Net Income Available to Common
21,047.00
133,145.00
180,951.00
221,573.00
EPS (Basic)
0.21
1.41
1.82
2.06
Basic Shares Outstanding
99,150.00
94,465.20
99,158.70
107,375.90
EPS (Diluted)
0.21
1.41
1.82
2.06
Diluted Shares Outstanding
99,150.00
94,465.20
99,158.70
107,375.90
EBITDA
21,046.10
133,148.00
180,250.00
204,200.00
About Axovant Sciences
View Profile
